TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11334904

Group type: EXPERIMENTAL
Intervention: Acute 72-hour fast (7 women in each group)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (7 women in each group, not fasting)
Number of subjects: 22
Study: 9235493

Group type: COMPARATOR
Intervention: 2.4 million units of penicillin G benzathine
Number of subjects: 541

Group type: EXPERIMENTAL
Intervention: Enhanced therapy with 2.4 million units of penicillin G benzathine plus a 10-day course of amoxicillin and probenecid
Number of subjects: 541
Study: 8496858

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (400 mg/day)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study: 3099588

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional therapy (control group)
Number of subjects: 54
Study: 31628465

Group type: EXPERIMENTAL
Intervention: PYY (0.4 pmol/kg/min)
Number of subjects: 18
Study: 30022357

Group type: EXPERIMENTAL
Intervention: Incredible Years Teacher Classroom Management Program (IY TCM)
Number of subjects: 1817
Study: 27529374

Group type: EXPERIMENTAL
Intervention: Aiming device used during operation (Experimental group)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no aiming device)
Number of subjects: 64
Study: 24731365

Group type: EXPERIMENTAL
Intervention: Soybean oligosaccharides (SBOS) combined with insulin treatment
Number of subjects: 97

Group type: COMPARATOR
Intervention: Insulin treatment
Number of subjects: 97
Study: 23250527

Group type: EXPERIMENTAL
Intervention: Imudon therapy in combination with traditional methods
Number of subjects: 320

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 320
Study: 20461807

Group type: EXPERIMENTAL
Intervention: Perampanel 0.5 mg
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Perampanel 1 mg
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Perampanel 2 mg
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: All perampanel groups
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 263
Study: 18371049

Group type: EXPERIMENTAL
Intervention: Lipolotion with 0.5% coriander oil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hydrocortisone (1.0%)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lipolotion with 1.0% coriander oil
Number of subjects: 40
Study: 16039873

Group type: EXPERIMENTAL
Intervention: Conjugated estrogen-progestin (E+P)
Number of subjects: 2763

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2763

Group type: EXPERIMENTAL
Intervention: Baseline serum UA levels
Number of subjects: 2763

Group type: EXPERIMENTAL
Intervention: On-study change in serum UA level
Number of subjects: 2763
Study: 14505813

Group type: EXPERIMENTAL
Intervention: 14 g/day fish oil (HFO)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 7 g/day of both safflower oil and fish oil (LFO)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 14 g/day safflower oil (SO)
Number of subjects: 30
Study: 11131946

Group type: EXPERIMENTAL
Intervention: High defensive subjects
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low defensive subjects
Number of subjects: 16
Study: 8805993

Group type: EXPERIMENTAL
Intervention: Clodronate (1600 mg/day, orally)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control (no clodronate treatment)
Number of subjects: 67
Study: 1289954

Group type: EXPERIMENTAL
Intervention: P‐30 composite resin
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Bisfil‐P composite resin
Number of subjects: 27

Group type: COMPARATOR
Intervention: Dispersalloy amalgam
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Composite resin restorations in molars
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Moderately sized composite resin restorations
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Composite resin with porous strontium glass filler
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Composite resin with zinc glass filler
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Unpolished amalgam
Number of subjects: 27
Study: 6397863

Group type: EXPERIMENTAL
Intervention: Naproxen sodium (1100 mg daily)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Mefenamic acid (1500 mg daily)
Number of subjects: 217
Study: 31257127

Group type: EXPERIMENTAL
Intervention: Cases without HIV infection and with positive chest x-rays
Number of subjects: 1769

Group type: EXPERIMENTAL
Intervention: Blood cultures
Number of subjects: 1769

Group type: EXPERIMENTAL
Intervention: Detection of pathogens in NP-OP specimens
Number of subjects: 1769

Group type: EXPERIMENTAL
Intervention: Aetiology analysis
Number of subjects: 1769

Group type: EXPERIMENTAL
Intervention: Very severe pneumonia cases
Number of subjects: 1769

Group type: EXPERIMENTAL
Intervention: RSV
Number of subjects: 1769

Group type: EXPERIMENTAL
Intervention: Aetiological distribution
Number of subjects: 1769

Group type: EXPERIMENTAL
Intervention: Differences in aetiological fraction by age and severity
Number of subjects: 1769

Group type: EXPERIMENTAL
Intervention: Leading ten pathogens
Number of subjects: 1769
Study: 29941028

Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HIIT) - 14 exercise sessions on a stationary cycle ergometer over 4-6 weeks, starting with 10 repeated 1-min blocks of intense exercise, progressing to 5 2-min intervals of high intensity exercise.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 27329438

Group type: EXPERIMENTAL
Intervention: 1 g of intravenous tranexamic acid (TXA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous saline (placebo)
Number of subjects: 0
Study: 23564447

Group type: EXPERIMENTAL
Intervention: Myocardial contrast echocardiography (MCE) and low-dose dobutamine stress echocardiography (LD-DSE) in Group B (n=27)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Myocardial contrast echocardiography (MCE) and low-dose dobutamine stress echocardiography (LD-DSE) in Group A (n=26)
Number of subjects: 53
Study: 22440854

Group type: EXPERIMENTAL
Intervention: High polyphenol content olive oil (HPC: 366 mg/kg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Low polyphenol content olive oil (LPC: 2.7 mg/kg)
Number of subjects: 18
Study: 20144692

Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS over the right DLPFC (140 s x 1 Hz) followed by controlateral sham (unilateral group, n=20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low frequency right DLPFC rTMS followed by left DLPFC high frequency rTMS (5 s x 10 Hz) (bilateral group, n=20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bilateral sham (sham group, n=20)
Number of subjects: 60
Study: 17294383

Group type: EXPERIMENTAL
Intervention: Fixed combination of bimatoprost 0.03%/timolol 0.5%
Number of subjects: 445

Group type: COMPARATOR
Intervention: Non-fixed combination treatment
Number of subjects: 445

Group type: COMPARATOR
Intervention: Bimatoprost alone
Number of subjects: 445
Study: 17060584

Group type: EXPERIMENTAL
Intervention: Atraumatic 22-gauge needle
Number of subjects: 58

Group type: COMPARATOR
Intervention: Traumatic 22-gauge needle
Number of subjects: 58
Study: 12714816

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured at admission, 24 hours, 15 days, and 30 days after admission.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) levels measured at admission, 24 hours, 15 days, and 30 days after admission.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Comparison of PCT and CRP sensitivity and specificity.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: PCT as a prognostic indicator for valve replacement and response to medical treatment.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: PCT levels to guide antimicrobial therapy before culture results.
Number of subjects: 50
Study: 10588312

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg orally once daily for 5 days
Number of subjects: 750

Group type: COMPARATOR
Intervention: Clarithromycin 500 mg orally twice daily for 7 days
Number of subjects: 750
Study: 8629205

Group type: EXPERIMENTAL
Intervention: Upper gastrointestinal endoscopy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Endoscopic thermal therapy (multipolar electrocautery or heater probe) and injection therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Urgent surgical intervention
Number of subjects: 30
Study: 1991216

Group type: EXPERIMENTAL
Intervention: 10 mg triamcinolone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 25 mg hydrocortisone
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2 ml 1% lignocaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20 mg triamcinolone
Number of subjects: 0
Study: 6340813

Group type: EXPERIMENTAL
Intervention: Natural prostaglandin E2 tablets
Number of subjects: 202

Group type: COMPARATOR
Intervention: Synthetic prostaglandin E2 tablets
Number of subjects: 202
Study: 31957252

Group type: EXPERIMENTAL
Intervention: Smelling amniotic fluid for 15 minutes before, during, and after peripheral cannulation
Number of subjects: 61

Group type: COMPARATOR
Intervention: Routine care during peripheral cannulation
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Smelling amniotic fluid
Number of subjects: 61

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 61
Study: 30888080

Group type: EXPERIMENTAL
Intervention: Teacher-delivered classroom lesson about sexual health
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Information materials about sexual health
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Free condom distribution in school corridors
Number of subjects: 168
Study: 28624695

Group type: EXPERIMENTAL
Intervention: S49076 (600 mg qd)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: S49076 (various doses from 15 to 900 mg)
Number of subjects: 103
Study: 27382587

Group type: EXPERIMENTAL
Intervention: SMS group (6 text messages a week for three months)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Reminder cards group (trained in how and in what order to use their cards)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 123
Study: 23963731

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM) 750 mg administered in one week
Number of subjects: 2584

Group type: COMPARATOR
Intervention: Iron sucrose 200 mg administered in up to five infusions in 14 days
Number of subjects: 2584

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 2584
Study: 22198902

Group type: EXPERIMENTAL
Intervention: OMRON M6
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Microlife BP A200 Plus
Number of subjects: 503
Study: 19615757

Group type: EXPERIMENTAL
Intervention: Schizophrenia group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non‐patient comparison subjects
Number of subjects: 60
Study: 17243646

Group type: EXPERIMENTAL
Intervention: BIS monitoring for sedation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Ramsay score monitoring for sedation
Number of subjects: 18
Study: 15124080

Group type: EXPERIMENTAL
Intervention: Topical application of Isatis tinctoria extracts during the ICD eliciting phase
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Topical application of tryptanthrin during the ICD eliciting phase
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Treatment after the eliciting phase
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Topical application of test substances in the UVB erythema model
Number of subjects: 20
Study: 11350435

Group type: EXPERIMENTAL
Intervention: Laparoscopic hernia repair
Number of subjects: 928

Group type: COMPARATOR
Intervention: Open hernia repair
Number of subjects: 928
Study: 9045315

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 0
Study: 8174444

Group type: EXPERIMENTAL
Intervention: High-monounsaturated fat (HM) diet
Number of subjects: 10

Group type: COMPARATOR
Intervention: High-carbohydrate (CHO) diet
Number of subjects: 10
Study: 3511207

Group type: EXPERIMENTAL
Intervention: Orally administered arginine free base 1 to 2 mmol/kg/day for 2 months (n = 13)
Number of subjects: 46

Group type: COMPARATOR
Intervention: No-treatment control group (n = 12)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both groups (hyperammonemic and normoammonemic)
Number of subjects: 46
Study: 31386891

Group type: EXPERIMENTAL
Intervention: 80 mg EMEND® capsules
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 125 mg EMEND® capsules
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vitro experiments with native surfactants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parameter Sensitivity Analysis (PSA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nano-sizing aprepitant
Number of subjects: 0
Study: 28753822

Group type: EXPERIMENTAL
Intervention: Robot-assisted radical prostatectomy (RARP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Laparoscopic radical prostatectomy (LRP)
Number of subjects: 120
Study: 24401221

Group type: EXPERIMENTAL
Intervention: RSV20/EZE10
Number of subjects: 833

Group type: EXPERIMENTAL
Intervention: RSV10/EZE10
Number of subjects: 833

Group type: EXPERIMENTAL
Intervention: Combination therapy (RSV10/EZE10 or RSV20/EZE10)
Number of subjects: 833

Group type: COMPARATOR
Intervention: Statin monotherapy
Number of subjects: 833

Group type: COMPARATOR
Intervention: Ezetimibe
Number of subjects: 833

Group type: COMPARATOR
Intervention: Rosuvastatin/ezetimibe and simvastatin/ezetimibe combinations
Number of subjects: 833
Study: 23919671

Group type: EXPERIMENTAL
Intervention: In-person navigator intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Informational pamphlet control
Number of subjects: 0
Study: 22254119

Group type: EXPERIMENTAL
Intervention: Green tea (GT) + water
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (PL) + water
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Green tea (GT) + 3.5 MP
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (PL) + 3.5 MP
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Green tea (GT) + 15 MP
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (PL) + 15 MP
Number of subjects: 18
Study: 18549436

Group type: COMPARATOR
Intervention: Basic Developmental Care (standardized nests and incubator covers)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Newborn Individualized Developmental Care and Assessment Program (NIDCAP)
Number of subjects: 264
Study: 17209488

Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone 10 mg
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 14593853

Group type: EXPERIMENTAL
Intervention: Bad medical news (BN)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Good medical news (GN)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (reading magazines)
Number of subjects: 25
Study: 10882628

Group type: EXPERIMENTAL
Intervention: Mebendazole (200 mg twice a day for 10 days)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Thiabendazole (25 mg/kg twice a day for 10 days)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Fluconazole (400 mg initially, then 200 mg daily for 10 days)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Thiabendazole and Mebendazole
Number of subjects: 46
Study: 8936542

Group type: COMPARATOR
Intervention: Succinylcholine 1 mg.kg‐1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vecuronium 0.16 mg.kg‐1 and Mivacurium 0.2 mg.kg‐1 (V2M2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vecuronium 0.08 mg.kg‐1 and Mivacurium 0.1 mg.kg‐1 (V1M1)
Number of subjects: 30
Study: 1406180

Group type: EXPERIMENTAL
Intervention: 7% carbohydrate‐electrolyte drink (CE)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 8
Study: 7015541

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sulindac
Number of subjects: 17
Study: 30980220

Group type: EXPERIMENTAL
Intervention: Lions Quest Skills for Adolescence (LQSFA) program
Number of subjects: 5196

Group type: COMPARATOR
Intervention: Regular curriculum (control group)
Number of subjects: 5196
Study: 26940798

Group type: EXPERIMENTAL
Intervention: Asynchronous video application on a mobile device
Number of subjects: 51

Group type: COMPARATOR
Intervention: Traditional outpatient physical therapy
Number of subjects: 51
Study: 25722977

Group type: EXPERIMENTAL
Intervention: Warm, humidified CO2 insufflation
Number of subjects: 97

Group type: COMPARATOR
Intervention: Cold‐dry CO2 insufflation
Number of subjects: 97
Study: 25608899

Group type: EXPERIMENTAL
Intervention: 30 µg/d mNGF by intramuscular injection for two courses (4 weeks for each course) with a 15-day interval
Number of subjects: 64

Group type: COMPARATOR
Intervention: Salvia miltiorrhiza Bunge and deproteinized extract of calf blood, methylcobalamin tablets, and vitamin B6
Number of subjects: 64
Study: 21095214

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 19687767

Group type: EXPERIMENTAL
Intervention: 0.5 mg sublingual testosterone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17050661

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lithium
Number of subjects: 0
Study: 16488712

Group type: COMPARATOR
Intervention: Lymph node sampling
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: Lymph node dissection
Number of subjects: 1023
Study: 12562651

Group type: EXPERIMENTAL
Intervention: GEM (1000 mg/m(2)) on days 1 and 8 and CBDCA (AUC 5 mg.min/ml) on day 1, 4 h before GEM (arm A)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: GEM on days 1 and 8 and CBDCA on day 2 (arm C)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: GEM on days 2 and 9 and CBDCA on day 1 (arm D)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: GEM (1000 mg/m(2)) on days 1 and 8 and CBDCA (AUC 5 mg.min/ml) on day 1, 4 h after GEM (arm B)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: CBDCA given before GEM
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 88
Study: 10232716

Group type: EXPERIMENTAL
Intervention: 1.3 MAC sevoflurane/N2O
Number of subjects: 24

Group type: COMPARATOR
Intervention: equi-MAC sevoflurane
Number of subjects: 24
Study: 8694085

Group type: EXPERIMENTAL
Intervention: Rimexolone 1% ophthalmic suspension
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1% prednisolone acetate
Number of subjects: 0
Study: 2007323

Group type: EXPERIMENTAL
Intervention: Nalmefene 25 mg orally
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nalmefene 50 mg orally
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nalmefene 100 mg orally
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Morphine 15 mg intramuscularly
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Morphine 30 mg intramuscularly
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 7097818

Group type: EXPERIMENTAL
Intervention: Silver sulfadiazine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 0
Study: 29175416

Group type: EXPERIMENTAL
Intervention: Autofluorescence-guided surgery (AF)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional surgery (non-AF)
Number of subjects: 36
Study: 28003205

Group type: EXPERIMENTAL
Intervention: 40 g freeze-dried strawberry powder added to a high-fat meal (50 g total fat)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control meal (high-fat meal without strawberry powder)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both meals (strawberry and control)
Number of subjects: 30
Study: 23714235

Group type: COMPARATOR
Intervention: Biphasic calcium phosphate (BCP) alone
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Biphasic calcium phosphate with autogenous bone (BCPAB)
Number of subjects: 8
Study: 23221616

Group type: EXPERIMENTAL
Intervention: Adventure-based training programme
Number of subjects: 120

Group type: COMPARATOR
Intervention: Attention placebo control group
Number of subjects: 120
Study: 21437932

Group type: EXPERIMENTAL
Intervention: Good collateral flow
Number of subjects: 287
Study: 18799887

Group type: EXPERIMENTAL
Intervention: Betadine vaginal preparation (not washed out)
Number of subjects: 721

Group type: COMPARATOR
Intervention: Control group (betadine cleansed by saline irrigation)
Number of subjects: 721
Study: 16171712

Group type: EXPERIMENTAL
Intervention: Myocardial perfusion imaging (MPI) using a gated dual-isotope protocol
Number of subjects: 357

Group type: COMPARATOR
Intervention: Angiography (reference standard)
Number of subjects: 357
Study: 12849673

Group type: EXPERIMENTAL
Intervention: Picotamide (a renal TxA(2) synthase and TxA(2)/prostaglandin H(2) receptor inhibitor)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Picotamide
Number of subjects: 14
Study: 10458353

Group type: EXPERIMENTAL
Intervention: Topical prostaglandin E1 gel plus 5% SEPA
Number of subjects: 48

Group type: COMPARATOR
Intervention: SEPA alone (placebo)
Number of subjects: 48
Study: 8911260

Group type: EXPERIMENTAL
Intervention: Comprehensive broad-spectrum empirical antimicrobial therapy (imipenem and cilastatin sodium, 500 mg, intravenously, every 6 hours)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Limited-spectrum empirical antimicrobial therapy (cefoxitin sodium, 2 g, intravenously, every 6 hours)
Number of subjects: 213
Study: 1875313

Group type: EXPERIMENTAL
Intervention: Bismuth Iodoform Paraffin Paste (BIPP) socket dressing
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Primary closure using a resorbable suture (Softgut)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Prophylactic metronidazole
Number of subjects: 148
Study: 7131550

Group type: EXPERIMENTAL
Intervention: Patient package insert (PPI)
Number of subjects: 249

Group type: COMPARATOR
Intervention: No patient package insert (non-PPI)
Number of subjects: 249
Study: 31050933

Group type: EXPERIMENTAL
Intervention: Diode Laser (DL) as an adjunct to Kirkland flap surgery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Kirkland flap surgery alone
Number of subjects: 20